NUVA - NuVasive, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
78.10
-1.26 (-1.59%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close79.36
Open79.85
Bid78.08 x 1300
Ask78.10 x 1200
Day's Range77.83 - 79.85
52 Week Range45.60 - 81.91
Volume593,247
Avg. Volume498,895
Market Cap4.067B
Beta (5Y Monthly)1.18
PE Ratio (TTM)86.87
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
All
News
Press Releases
  • NuVasive Announces Preliminary Unaudited Fourth Quarter and Full Year 2019 Revenue Results
    PR Newswire

    NuVasive Announces Preliminary Unaudited Fourth Quarter and Full Year 2019 Revenue Results

    NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced preliminary unaudited revenue results for the fourth quarter and full year 2019.

  • NuVasive to Participate in 38th Annual J.P. Morgan Healthcare Conference
    PR Newswire

    NuVasive to Participate in 38th Annual J.P. Morgan Healthcare Conference

    NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that management will present at the 38th Annual J.P. Morgan Healthcare Conference at the Westin St. Francis in San Francisco on Wednesday, Jan. 15, at 10:00 a.m. PT/1:00 p.m. ET.

  • NuVasive Appoints Matthew K. Harbaugh as Chief Financial Officer
    PR Newswire

    NuVasive Appoints Matthew K. Harbaugh as Chief Financial Officer

    NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the appointment of Matthew K. Harbaugh as executive vice president and chief financial officer (CFO) effective immediately. Mr. Harbaugh succeeds Rajesh (Raj) J. Asarpota, who will transition from the Company.

  • NuVasive Receives FDA Clearance for Expanded Multi-Level Use of CoRoent Small Interlock™ System for the Cervical Spine
    PR Newswire

    NuVasive Receives FDA Clearance for Expanded Multi-Level Use of CoRoent Small Interlock™ System for the Cervical Spine

    SAN DIEGO, Nov. 21, 2019 /PRNewswire/ -- NuVasive, Inc. (NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the Company received U.S. Food and Drug Administration (FDA) 510(k) clearance for expanded indications for the CoRoent Small Interlock™ system. The expanded indication allows for on-label use of the device at multiple contiguous levels from C2-T1 for anterior cervical discectomy and fusion (ACDF) procedures, compared to other systems on the market cleared for only one- or two-level use. ACDF is a commonly performed surgery to address cervical disc degeneration or spinal instability.

  • NuVasive to Participate as Double Diamond Sponsor at the 13th International Congress on Early Onset Scoliosis and Host the MAGEC® Users Meeting
    PR Newswire

    NuVasive to Participate as Double Diamond Sponsor at the 13th International Congress on Early Onset Scoliosis and Host the MAGEC® Users Meeting

    SAN DIEGO, Nov. 14, 2019 /PRNewswire/ -- NuVasive, Inc. (NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the Company will participate as a double diamond sponsor at the 13th International Congress on Early Onset Scoliosis (ICEOS), November 21-22, 2019 at the Westin Peachtree Plaza in Atlanta. At the same location, on November 23, 2019, NuVasive will host the fourth annual MAGEC® Users Meeting.

  • NuVasive to Participate as Gold Sponsor at the Cervical Spine Research Society 47th Annual Meeting
    PR Newswire

    NuVasive to Participate as Gold Sponsor at the Cervical Spine Research Society 47th Annual Meeting

    SAN DIEGO, Nov. 13, 2019 /PRNewswire/ -- NuVasive, Inc. (NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the Company will participate as a gold sponsor at the Cervical Spine Research Society (CSRS) 47th Annual Meeting, November 21-23, 2019 at the New York Marriott Marquis in New York City. "NuVasive's involvement at CSRS showcases our commitment to invest in and deliver cervical solutions to surgeons and patients," said Matt Link, president of NuVasive. NuVasive's booth #307 will display its Advanced Materials Science™ cervical portfolio, which includes proprietary surface and structural technologies to enhance the osseointegration and biomechanical properties of surgical materials.

  • NuVasive to Present at the 28th Annual Credit Suisse Healthcare Conference
    PR Newswire

    NuVasive to Present at the 28th Annual Credit Suisse Healthcare Conference

    SAN DIEGO, Nov. 4, 2019 /PRNewswire/ -- NuVasive, Inc. (NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that management will present at the 28th Annual Credit Suisse Healthcare Conference at The Phoenician in Scottsdale, Arizona on Tuesday, November 12, 2019, at 1:50 p.m. MST/ 3:50 p.m. EST. A live webcast of the presentation will be available online from the Investor Relations page of the Company's website at www.nuvasive.com. NuVasive, Inc. (NUVA) is the leader in spine technology innovation, focused on transforming spine surgery and beyond with minimally disruptive, procedurally integrated solutions designed to deliver reproducible and clinically-proven surgical outcomes.

  • NuVasive Announces Third Quarter 2019 Financial Results
    PR Newswire

    NuVasive Announces Third Quarter 2019 Financial Results

    SAN DIEGO , Oct. 30, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated ...

  • NuVasive Announces Conference Call and Webcast of Third Quarter 2019 Results
    PR Newswire

    NuVasive Announces Conference Call and Webcast of Third Quarter 2019 Results

    SAN DIEGO, Oct. 14, 2019 /PRNewswire/ -- NuVasive, Inc. (NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the Company will release its third quarter 2019 earnings results on Wednesday, October 30, 2019 after the close of the market. NuVasive will hold a conference call on Wednesday, October 30, 2019, at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results of its financial performance for the third quarter 2019. The dial-in numbers are 1-877-407-9039 for domestic callers and 1-201-689-8470 for international callers.

  • NuVasive to Participate as Gold Sponsor at the EUROSPINE 2019 Annual Meeting
    PR Newswire

    NuVasive to Participate as Gold Sponsor at the EUROSPINE 2019 Annual Meeting

    SAN DIEGO, Oct. 9, 2019 /PRNewswire/ -- NuVasive, Inc. (NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced it will participate as a gold sponsor at the EUROSPINE 2019 Annual Meeting held October 16-18, 2019 in Helsinki, Finland. "NuVasive is driven to deliver technologies that enable less invasive surgical techniques to patients and surgeons globally," said Erin McEachren, commercial vice president of Europe at NuVasive. NuVasive will host a lunch workshop, X360™, A Comprehensive Approach to Lateral Single-Position Surgery on Friday, October 18 from 12:00 to 2:00 p.m. EEST in Room 203 of Messukeskus Helsinki Expo and Convention Center.

  • NuVasive to Demonstrate Enabling Technologies to Accelerate the Adoption of Less Invasive Spine Surgery at NASS 2019
    PR Newswire

    NuVasive to Demonstrate Enabling Technologies to Accelerate the Adoption of Less Invasive Spine Surgery at NASS 2019

    SAN DIEGO, Sept. 25, 2019 /PRNewswire/ -- NuVasive, Inc. (NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the Company will highlight its enabling technologies at the North American Spine Society (NASS) Annual Meeting, September 25-28, 2019 at McCormick Place in Chicago. "As part of NuVasive's commitment to transform surgery, at NASS we will showcase enabling technologies that help surgeons perform less invasive spine procedures," said Matt Link, president of NuVasive.

  • NuVasive LessRay® Platform Wins 2019 Spine Technology Award from Orthopedics This Week
    PR Newswire

    NuVasive LessRay® Platform Wins 2019 Spine Technology Award from Orthopedics This Week

    SAN DIEGO , Sept. 23, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated ...

  • NuVasive to Participate as Double Diamond Sponsor at Scoliosis Research Society Annual Meeting
    PR Newswire

    NuVasive to Participate as Double Diamond Sponsor at Scoliosis Research Society Annual Meeting

    SAN DIEGO, Sept. 11, 2019 /PRNewswire/ -- NuVasive, Inc. (NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced it will participate as a double diamond sponsor at the Scoliosis Research Society (SRS) 54th Annual Meeting held September 18-21, 2019 in Montréal, Canada. "NuVasive is committed to building the leading complex deformity portfolio in spine and we are pleased to continue our support of the Scoliosis Research Society as a double diamond sponsor," said Matt Link, president of NuVasive.

  • GlobeNewswire

    Alphatec Announces Favorable Judgment in NuVasive v. Miles Lawsuit

    Alphatec Holdings, Inc. (“ATEC” or “the Company”) (ATEC), a medical device company dedicated to revolutionizing the approach to spine surgery, announced today that the Delaware Chancery Court entered summary judgment in favor of its Chairman and Chief Executive Officer, Pat Miles, terminating all non-competition and employee non-solicitation claims brought against Miles and the Company by competitor, NuVasive, Inc. (NUVA).

  • NuVasive to Participate in Investor Events in September 2019
    PR Newswire

    NuVasive to Participate in Investor Events in September 2019

    NuVasive, Inc. (NUVA) is the leader in spine technology innovation, focused on transforming spine surgery and beyond with minimally disruptive, procedurally integrated solutions designed to deliver reproducible and clinically-proven surgical outcomes. The Company's portfolio includes access instruments, implantable hardware, biologics, software systems for surgical planning, navigation and imaging solutions, magnetically adjustable implant systems for spine and orthopedics, and intraoperative monitoring service offerings.

  • NuVasive Expands its Advanced Materials Science™ Portfolio to Offer Porous Titanium Spine Implants for all TLIF Procedures
    PR Newswire

    NuVasive Expands its Advanced Materials Science™ Portfolio to Offer Porous Titanium Spine Implants for all TLIF Procedures

    SAN DIEGO, Aug. 20, 2019 /PRNewswire/ -- NuVasive, Inc. (NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the commercial launch of Modulus® TLIF-A, a porous titanium spine implant engineered for the transforaminal lumbar interbody fusion (TLIF) procedure. This offering completes the Company's Advanced Materials Science™ (AMS) portfolio for all major posterior interbody fusion techniques used in TLIF, the most commonly performed procedure in the spine industry. The availability of Modulus TLIF-A further extends NuVasive's technology offerings in the spinal deformity market given its differentiated ability to provide anterior column support, increase segmental lordosis and maximize capability to restore sagittal alignment.

  • NuVasive Specialized Orthopedics Reaches 10,000 Nail Implant Milestone of the Precice® System for Limb Lengthening
    PR Newswire

    NuVasive Specialized Orthopedics Reaches 10,000 Nail Implant Milestone of the Precice® System for Limb Lengthening

    SAN DIEGO, Aug. 14, 2019 /PRNewswire/ -- NuVasive, Inc. (NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced a milestone of 10,000 implants of the Precice® system for conditions related to limb lengthening and reconstruction from NuVasive Specialized Orthopedics™. "Precice has completely changed the game in limb lengthening and reconstruction surgery and is rapidly becoming the gold standard of care for patients with conditions related to limb-length discrepancy," said Stuart Green, MD, orthopedic surgeon at UC Irvine School of Medicine. "Before Precice, patients were limited to bulky, painful external fixation devices that significantly impacted their mobility and comfort.

  • NuVasive Presents Long-Term Strategy and Financial Outlook at 2019 Investor Day
    PR Newswire

    NuVasive Presents Long-Term Strategy and Financial Outlook at 2019 Investor Day

    SAN DIEGO, Aug. 8, 2019 /PRNewswire/ -- NuVasive, Inc. (NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today is hosting its 2019 Investor Day in New York City with presentations by Chief Executive Officer J. Christopher Barry and other members of the management team. "At NuVasive's 2019 Investor Day, I look forward to sharing the Company's go-forward strategy to build on our foundation as the innovation leader in spine with a roadmap to deliver sustained, above-market growth," said J. Christopher Barry, chief executive officer of NuVasive.

  • NuVasive Announces Second Quarter 2019 Financial Results
    PR Newswire

    NuVasive Announces Second Quarter 2019 Financial Results

    SAN DIEGO , July 30, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated ...

  • ACCESSWIRE

    NuVasive, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / July, 30 2019 / NuVasive, Inc. (NYSE: NUVA ) will be discussing their earnings results in their 2019 Second Quarter Earnings to be held on July, 30 2019 at 4:30 PM Eastern Time. ...

  • NuVasive Announces Conference Call and Webcast of Second Quarter 2019 Results
    PR Newswire

    NuVasive Announces Conference Call and Webcast of Second Quarter 2019 Results

    SAN DIEGO, July 15, 2019 /PRNewswire/ -- NuVasive, Inc. (NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the Company will release its second quarter 2019 earnings results on Tuesday, July 30, 2019 after the close of the market. NuVasive will hold a conference call on Tuesday, July 30, 2019, at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results of its financial performance for the second quarter 2019. The dial-in numbers are 1-877-407-9039 for domestic callers and 1-201-689-8470 for international callers.

  • GlobeNewswire

    Evolus Expands Board of Directors with Appointment of Independent Directors Peter Farrell, Ph.D. and Karah Parschauer, J.D.

    NEWPORT BEACH, Calif., July 15, 2019 -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products,.

  • NuVasive to Participate as Double Diamond Sponsor at 2019 International Meeting on Advanced Spine Techniques
    PR Newswire

    NuVasive to Participate as Double Diamond Sponsor at 2019 International Meeting on Advanced Spine Techniques

    SAN DIEGO, July 11, 2019 /PRNewswire/ -- NuVasive, Inc. (NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the Company is continuing its commitment to the Scoliosis Research Society as a Double Diamond sponsor of the 26th International Meeting on Advanced Spine Techniques (IMAST) being held July 17-20, 2019 at the RAI Amsterdam Convention Centre. NuVasive will highlight its leading solutions for adult and pediatric complex spine surgery and comprehensive approach to lateral single-position surgery with the X360™ system integrated with Surgical Intelligence™. During the meeting, NuVasive will host a lunch workshop, Advanced Techniques in Complex Deformity Procedures, presented by Tyler Koski, MD, and Christopher Shaffrey, MD, on July 18, 2019 from 1:05 to 2:05 p.m. CEST in room G105.

  • NuVasive Launches Pulse™-The First Integrated Technology Platform to Enable Better Spine Surgery
    PR Newswire

    NuVasive Launches Pulse™-The First Integrated Technology Platform to Enable Better Spine Surgery

    Early clinical experience demonstrates the Pulse system's utility to improve workflow, reduce surgical variability and increase reproducibility of surgical outcomes SAN DIEGO , July 10, 2019 /PRNewswire/ ...

  • NuVasive Expands Advanced Materials Science™ Portfolio with Launch of Porous Titanium Spine Implant for Transforaminal Lumbar Interbody Fusion
    PR Newswire

    NuVasive Expands Advanced Materials Science™ Portfolio with Launch of Porous Titanium Spine Implant for Transforaminal Lumbar Interbody Fusion

    SAN DIEGO, June 17, 2019 /PRNewswire/ -- NuVasive, Inc. (NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the commercial launch of Modulus® TLIF-O, a porous titanium spine implant engineered for the transforaminal lumbar interbody fusion (TLIF) procedure. This further expands the application of the Company's Advanced Materials Science™ (AMS) portfolio to more of its procedural offerings and the most commonly performed procedure in the spine industry. Modulus TLIF-O features porous surface technology that, based on pre-clinical data, provides a favorable environment for bone in-growth and bone on-growth, and consistently achieves stronger osseointegration than solid implants with smooth or rough surfaces.1-4 The porous and roughened endplate design promotes new bone on-growth at four weeks and demonstrates the greatest integration strength by 12 weeks compared to alternative implant materials.5 Modulus TLIF-O's lattice structure is optimized for each implant size through NuVasive's proprietary algorithm that balances strength and radiolucency, while also mimicking the stiffness of bone.5 This optimized lattice structure enables enhanced imaging for visualization of spinal fusion compared to solid titanium interbody implants.